October 8, 2020 Sophia Vida
Biotech & Pharma

Eli Lilly Shares Soar After Company Requests FDA Clearance for Antibody Drug

Shares of Eli Lilly were on the rise on Wednesday after Wall Street learned that the company is seeking FDA clearance for its COVID-19 antibody treatment. The company announced that it has submitted a request to the U.S. Food and Drug Administration for emergency authorization of the drug LY-CoV555. LY-CoV555 belongs to a class of … Continue reading “Eli Lilly Shares Soar After Company Requests FDA Clearance for Antibody Drug”